IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Invus Financial Advisors, LLC

Q3 2020 Holdings

Filed 2020-11-16 | 6 holdings | $31.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc(RCUS)COM03969F109$31.6M1,842,07799.4%
Oyster Point Pharma IncCOM69242L106$58.4K2,768,5860.2%
Yext Inc(YEXT)COM98585N106$49.8K3,280,8850.2%
Novocure Ltd(NVCR)ORD SHSG6674U108$39.1K350,8840.1%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$25.2K1,007,5760.1%
Unity Biotechnology IncCOM91381U101$3.8K1,094,9980.0%